Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy

In recent decades, a new method of cellular immunotherapy was introduced based on engineering and empowering the immune effector cells. In this type of immunotherapy, the immune effector cells are equipped with chimeric antigen receptor (CAR) to specifically target cancer cells. In much of the trial...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Stem Cell Res Ther
Auteurs principaux: Marofi, Faroogh, Rahman, Heshu Sulaiman, Thangavelu, Lakshmi, Dorofeev, Aleksey, Bayas-Morejón, Favian, Shirafkan, Naghmeh, Shomali, Navid, Chartrand, Max Stanley, Jarahian, Mostafa, Vahedi, Ghasem, Mohammed, Rebar N., Shahrokh, Somayeh, Akbari, Morteza, Khiavi, Farhad Motavalli
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7983395/
https://ncbi.nlm.nih.gov/pubmed/33752707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-021-02251-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires